Inhibition of DPP-4 by alogliptin improves coronary flow reserve and left ventricular systolic function evaluated by phase contrast cine magnetic resonance imaging in patients with type 2 diabetes and coronary artery disease-Reference-Cited by-同舟云学术

Inhibition of DPP-4 by alogliptin improves coronary flow reserve and left ventricular systolic function evaluated by phase contrast cine magnetic resonance imaging in patients with type 2 diabetes and coronary artery disease

Published:2016-11 Issue: Volume:223 Page:770-775
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

Kato Shingo,Fukui Kazuki,Kirigaya Hidekuni,Gyotoku Daiki,Iinuma Naoki,Kusakawa Yuka,Iguchi Kohei,Nakachi Tatsuya,Iwasawa Tae,Kimura Kazuo

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference25 articles.

1. Epidemiology of cardiovascular complications in type 2 diabetes mellitus;Meigs;Acta Diabetol.,2003

2. Trends in all-cause and cardiovascular disease mortality among women and men with and without diabetes mellitus in the Framingham Heart Study, 1950 to 2005;Preis;Circulation,2009

3. Heart disease and stroke statistics—2013 update: a report from the American Heart Association;Go;Circulation,2013

4. Inhibition of the activity of dipeptidyl-peptidase IV as a treatment for type 2 diabetes;Holst;Diabetes,1998

5. Alogliptin: a novel molecule for improving glycemic control in type II diabetes mellitus;Ghatak;Curr. Diabetes Rev.,2010

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effects of dipeptidyl peptidase-4 inhibitors on cardiac structure and function using cardiac magnetic resonance: a meta-analysis of clinical studies;Frontiers in Endocrinology;2024-09-11

2. Determinants of Health-Related Quality of Life in Outpatients with Myocardial Infarction;Journal of Multidisciplinary Healthcare;2024-05

3. Novel Approaches to the Management of Diabetes Mellitus in Patients with Coronary Artery Disease;Current Pharmaceutical Design;2023-09-06

4. Incretins-Based Therapies and Their Cardiovascular Effects: New Game-Changers for the Management of Patients with Diabetes and Cardiovascular Disease;Pharmaceutics;2023-07-01

5. Effects of new hypoglycemic drugs on cardiac remodeling: a systematic review and network meta-analysis;BMC Cardiovascular Disorders;2023-06-09